One of this year's Kavli Prize winners is Robert Langer, one of the founders of the pharmaceutical giant Moderna.
When Robert S. Langer finished his chemical engineering degree in 1974, he received lucrative job offers from several oil companies. However, he chose a different path and used his engineering expertise to revolutionize medical research. He was the first to develop nanomaterials that enabled medicine to gradually release active ingredients in the body.
He had a key role in developing the mRNA vaccine and in the founding of Moderna – the company behind one of the most widely used COVID vaccines.
Langer receives the 2024 Kavli Prize in Nanoscience along with Armand Paul Alivisatos and Chad A. Mirkin. They have also contributed with important research on nanoparticles for medical use, in particular for diagnostic purposes.
The citation states that they "have revolutionized the field of nanomedicine by demonstrating how nanotechnology can advance biomedical research and practice."
As part of the Kavli Prize Week program, they gave lectures about their research at Oslo Science Park.